A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis. (2013)
Attributed to:
Edinburgh Trials Methodology Hub
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/thoraxjnl-2013-203309
PubMed Identifier: 23525080
Publication URI: http://europepmc.org/abstract/MED/23525080
Type: Journal Article/Review
Volume: 68
Parent Publication: Thorax
Issue: 11
ISSN: 0040-6376